EOS imaging has secured approval from the US Food and Drug Administration (FDA) for its spineEOS, a new online 3D planning software for spine surgery.


Based on EOS stereo-radiographic 2D/3D imaging, the new 3D planning software enables to treat adults suffering from degenerative or deformative spine conditions, as well as pediatric patients with adolescent idiopathic scoliosis.

The new software helps surgeon to create a treatment plan to attain optimal sagittal alignment from pelvic and vertebral 3D data obtained in the functional standing position from an EOS exam.

The planned surgery and virtual post-correction 3D anatomy will be used to precisely plan for the 3D shape and length of the spinal implants.

In addition, it can be shared pre-operatively to engage the patient in the intended course of therapy, and is accessible in the operating room through a custom planning report.

EOS imaging CEO Marie Meynadier said: "We believe that patients’ spines are complex 3D systems that need a personalized 3D planning of the intended surgery.

"We’re excited about the interest we’ve seen in our spineEOS planning software from surgeons inside and outside of our current installed base, as well as from our industry partners."

EOS medical imaging system is used in osteoarticular pathologies and orthopaedics, as well as associated solutions.

It was approved to market in 51 countries, including the US, Japan, China, and the European Union (EC).

Image: EOS imaging has received FDA approval for new 3D planning software for spine surgery. Photo: courtesy of Stuart Miles / FreeDigitalPhotos.net.